Thromboembolism incidence and prophylaxis during vaginal delivery hospitalizations

Published:September 18, 2014DOI:


      Although major international guidelines recommend venous thromboembolism (VTE) prophylaxis during vaginal delivery hospitalization for women with additional risk factors, US guidelines recommend prophylaxis for a very small number of women who are at particularly high risk for an event. The purpose of this study was to characterize practice patterns of VTE prophylaxis in the United States during vaginal delivery hospitalizations and to determine VTE incidence in this population.

      Study Design

      A population-level database was used to analyze VTE incidence and use of VTE prophylaxis during vaginal delivery hospitalizations in the United States between 2006 and 2012 (n = 2,673,986). We evaluated whether patients received either pharmacologic or mechanical prophylaxis. Hospital-level factors and patient characteristics were included in multivariable regression analysis that evaluated prophylaxis administration.


      We identified 2,673,986 women who underwent vaginal delivery. Incidence of VTE increased during the study period from 15.6-29.8 events per 100,000 delivery hospitalizations. Within the cohort, 2.6% of patients (n = 68,835) received VTE prophylaxis. Pharmacologic prophylaxis was rare; <1% of women received unfractionated or low-molecular-weight heparin. Although patients with thrombophilia or a previous VTE event were likely to receive prophylaxis (60.8% and 72.8%, respectively), patients with risk factors for VTE such as obesity, smoking, and heart disease were unlikely to receive prophylaxis (rates of 5.9%, 3.3%, and 6.2%, respectively).


      Our findings demonstrate that the administration of VTE prophylaxis outside a small group of women at extremely high risk for VTE is rare during vaginal delivery hospitalization. Given that VTE incidence is rising in this population, further research to determine whether broadening prophylaxis for VTE may reduce severe maternal morbidity and death is indicated.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Khan K.S.
        • Wojdyla D.
        • Say L.
        • Gulmezoglu A.M.
        • Van Look P.F.
        WHO analysis of causes of maternal death: a systematic review.
        Lancet. 2006; 367: 1066-1074
      1. Centers for Disease Control and Prevention. Pregnancy Mortality Surveillance System. [cited 2014 August 1]; Available at: Accessed Oct. 6, 2014.

        • Clark S.L.
        • Belfort M.A.
        • Dildy G.A.
        • Herbst M.A.
        • Meyers J.A.
        • Hankins G.D.
        Maternal death in the 21st century: causes, prevention, and relationship to cesarean delivery.
        Am J Obstet Gynecol. 2008; 199 (discussion 91-2.e7-11): 36.e1-36.e5
        • James A.
        • Committee on Practice Bulletins–Obstetrics
        Thromboembolism in pregnancy. Practice bulletin no. 123.
        Obstet Gynecol. 2011; 118: 718-729
        • Quinones J.N.
        • James D.N.
        • Stamilio D.M.
        • Cleary K.L.
        • Macones G.A.
        Thromboprophylaxis after cesarean delivery: a decision analysis.
        Obstet Gynecol. 2005; 106: 733-740
        • Casele H.
        • Grobman W.A.
        Cost-effectiveness of thromboprophylaxis with intermittent pneumatic compression at cesarean delivery.
        Obstet Gynecol. 2006; 108: 535-540
        • Bates S.M.
        • Greer I.A.
        • Middeldorp S.
        • et al.
        VTE, thrombophilia, antithrombotic therapy, and pregnancy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
        Chest. 2012; 141: e691S-e736S
        • Friedman A.M.
        • Ananth C.V.
        • Lu Y.S.
        • D'Alton M.E.
        • Wright J.D.
        Underuse of postcesarean thromboembolism prophylaxis.
        Obstet Gynecol. 2013; 122: 1197-1204
        • Ghaji N.
        • Boulet S.L.
        • Tepper N.
        • Hooper W.C.
        Trends in venous thromboembolism among pregnancy-related hospitalizations, United States, 1994-2009.
        Am J Obstet Gynecol. 2013; 209: 433.e1-433.e8
        • Callaghan W.M.
        • Creanga A.A.
        • Kuklina E.V.
        Severe maternal morbidity among delivery and postpartum hospitalizations in the United States.
        Obstet Gynecol. 2012; 120: 1029-1036
        • Jacobsen A.F.
        • Skjeldestad F.E.
        • Sandset P.M.
        Incidence and risk patterns of venous thromboembolism in pregnancy and puerperium: a register-based case-control study.
        Am J Obstet Gynecol. 2008; 198: 233.e1-233.e7
        • James A.H.
        • Jamison M.G.
        • Brancazio L.R.
        • Myers E.R.
        Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality.
        Am J Obstet Gynecol. 2006; 194: 1311-1315
        • Sultan A.A.
        • et al.
        Risk factors for first venous thromboembolism around pregnancy: a population-based cohort study from the United Kingdom.
        Blood. 2013; 121: 3953-3961
        • Cantwell R.
        • Clutton-Brock T.
        • Cooper G.
        • et al.
        Saving mothers' lives: reviewing maternal deaths to make motherhood safer: 2006-2008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom.
        BJOG. 2011; 118: 1-203
        • Royal College of Obstetricians and Gynaecologists
        Thrombosis and embolism during pregnancy and the puerperium, reducing the risk (Green-Top Guideline no. 37a).
        Royal College of Obstetricians and Gynaecologists, London2009
        • Stulberg J.J.
        • Delaney C.P.
        • Neuhauser D.V.
        • Aron D.C.
        • Fu P.
        • Koroukian S.M.
        Adherence to surgical care improvement project measures and the association with postoperative infections.
        JAMA. 2010; 303: 2479-2485
        • Lindenauer P.K.
        • Pekow P.S.
        • Lahti M.C.
        • Lee Y.
        • Benjamin E.M.
        • Rothberg M.B.
        Association of corticosteroid dose and route of administration with risk of treatment failure in acute exacerbation of chronic obstructive pulmonary disease.
        JAMA. 2010; 303: 2359-2367
        • Rothberg M.B.
        • Pekow P.S.
        • Lahti M.
        • Brody O.
        • Skiest D.J.
        • Lindenauer P.K.
        Antibiotic therapy and treatment failure in patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease.
        JAMA. 2010; 303: 2035-2042
        • Fang M.C.
        • Maselli J.
        • Lurie J.D.
        • Lindenauer P.K.
        • Pekow P.S.
        • Auerbach A.D.
        Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.
        J Thromb Haemost. 2011; 9: 1318-1325
        • Ritch J.M.
        • Kim J.H.
        • Lewin S.N.
        • et al.
        Venous thromboembolism and use of prophylaxis among women undergoing laparoscopic hysterectomy.
        Obstet Gynecol. 2011; 117: 1367-1374
        • Wright J.D.
        • Lewin S.N.
        • Shah M.
        • et al.
        Quality of venous thromboembolism prophylaxis in patients undergoing oncologic surgery.
        Ann Surg. 2011; 253: 1140-1146
        • Kuklina E.V.
        • Whiteman M.K.
        • Hillis S.D.
        • et al.
        An enhanced method for identifying obstetric deliveries: implications for estimating maternal morbidity.
        Matern Child Health J. 2008; 12: 469-477
        • Bates S.M.
        • Greer I.A.
        • Pabinger I.
        • Sofaer S.
        • Hirsh J.
        American College of Chest P. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians evidence-based clinical practice guidelines (8th ed).
        Chest. 2008; 133: 844S-886S
        • Chan W.S.
        The “ART” of thrombosis: a review of arterial and venous thrombosis in assisted reproductive technology.
        Curr Opin Obstet Gynecol. 2009; 21: 207-218
        • Danilenko-Dixon D.R.
        • Heit J.A.
        • Silverstein M.D.
        • et al.
        Risk factors for deep vein thrombosis and pulmonary embolism during pregnancy or post partum: a population-based, case-control study.
        Am J Obstet Gynecol. 2001; 184: 104-110
        • Dargaud Y.
        • Rugeri L.
        • Vergnes M.C.
        • et al.
        A risk score for the management of pregnant women with increased risk of venous thromboembolism: a multicentre prospective study.
        Br J Haematol. 2009; 145: 825-835
        • Goldhaber S.Z.
        Risk factors for venous thromboembolism.
        J Am Coll Cardiol. 2010; 56: 1-7
        • James A.H.
        Thromboembolism in pregnancy: recurrence risks, prevention and management.
        Curr Opin Obstet Gynecol. 2008; 20: 550-556
        • Larsen T.B.
        • Sorensen H.T.
        • Gislum M.
        • Johnsen S.P.
        Maternal smoking, obesity, and risk of venous thromboembolism during pregnancy and the puerperium: a population-based nested case-control study.
        Thromb Res. 2007; 120: 505-509
        • Lindqvist P.G.
        • Torsson J.
        • Almqvist A.
        • Bjorgell O.
        Postpartum thromboembolism: severe events might be preventable using a new risk score model.
        Vasc Health Risk Manag. 2008; 4: 1081-1087
        • Lussana F.
        • Coppens M.
        • Cattaneo M.
        • Middeldorp S.
        Pregnancy-related venous thromboembolism: risk and the effect of thromboprophylaxis.
        Thromb Res. 2012; 129: 673-680
        • Sultan A.A.
        • West J.
        • Tata L.J.
        • Fleming K.M.
        • Nelson-Piercy C.
        • Grainge M.J.
        Risk of first venous thromboembolism in and around pregnancy: a population-based cohort study.
        Br J Haematol. 2012; 156: 366-373
        • Tooher R.
        • Gates S.
        • Dowswell T.
        • Davis L.J.
        Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period.
        Cochrane Database Syst Rev. 2010; : CD001689
        • Elixhauser A.
        • Steiner C.
        • Harris D.R.
        • Coffey R.M.
        Comorbidity measures for use with administrative data.
        Med Care. 1998; 36: 8-27
        • Bateman B.T.
        • Mhyre J.M.
        • Hernandez-Diaz S.
        • et al.
        Development of a comorbidity index for use in obstetric patients.
        Obstet Gynecol. 2013; 122: 957-965
        • Flegal K.M.
        • Carroll M.D.
        • Kit B.K.
        • Ogden C.L.
        Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010.
        JAMA. 2012; 307: 491-497
        • Hamilton B.E.
        • Martin J.A.
        • Ventura S.J.
        Births: preliminary data for 2012.
        Natl Vital Stat Rep. 2013; 62: 1-20
        • Amin A.N.
        • Stemkowski S.
        • Lin J.
        • Yang G.
        Preventing venous thromboembolism in US hospitals: are surgical patients receiving appropriate prophylaxis?.
        Thromb Haemost. 2008; 99: 796-797
        • Amin A.N.
        • Stemkowski S.
        • Lin J.
        • Yang G.
        Inpatient thromboprophylaxis use in U.S. hospitals: adherence to the seventh American College of Chest Physician's recommendations for at-risk medical and surgical patients.
        J Hosp Med. 2009; 4: E15-E21
        • Lindenauer P.K.
        • Pekow P.
        • Gao S.
        • Crawford A.S.
        • Gutierrez B.
        • Benjamin E.M.
        Quality of care for patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease.
        Ann Intern Med. 2006; 144: 894-903
        • Bockheim H.M.
        • McAllen K.J.
        • Baker R.
        • Barletta J.F.
        Mechanical prophylaxis to prevent venous thromboembolism in surgical patients: a prospective trial evaluating compliance.
        J Crit Care. 2009; 24: 192-196
        • Macatangay C.
        • Todd S.R.
        • Tyroch A.H.
        Thromboembolic prophylaxis with intermittent pneumatic compression devices in trauma patients: a false sense of security?.
        J Trauma Nurs. 2008; 15: 12-15
        • White R.H.
        • Brickner L.A.
        • Scannell K.A.
        ICD-9-CM codes poorly indentified venous thromboembolism during pregnancy.
        J Clin Epidemiol. 2004; 57: 985-988
        • White R.H.
        • Garcia M.
        • Sadeghi B.
        • et al.
        Evaluation of the predictive value of ICD-9-CM coded administrative data for venous thromboembolism in the United States.
        Thromb Res. 2010; 126: 61-67